Anterogen.Co.Ltd

Anterogen.Co.,Ltd. is a bio-venture company that researches, develops, and commercializes stem cell therapy products based on adipose-derived stem cells in South Korea and internationally. Its medicines include Cupistem injection for Crohn's fistula, Queencell, a stromal vascular fraction for regeneration of subcutaneous adipose tissue, and Remodulin injection for pulmonary arterial hypertension. The company also offers hair and skin care cosmetics, such as SCM2, SCM2-Black, Therastem-Derma, Therastem-White Silk, and Therastem-White Glutathione, along with human stem cell conditioned media as a cosmetic raw material. In addition, it provides cell banking services and analysis services, including sample analysis for clinical studies and biopharmaceutical tests for identification, purity, potency, and adventitious virus. Founded in 2000, Anterogen.Co.,Ltd. is headquartered in Seoul, South Korea.